序号 |
标题 |
次数 |
作者 |
发布时间 |
64801 |
枸橼酸托法替尼脂质体,Tofacitinib Citrate Liposome |
101 |
axc |
2024-12-25 |
64802 |
cas:2028284-70-8,Sulfo DBCO-amine,抗体偶联药物 |
62 |
h |
2024-12-25 |
64803 |
四苯基卟啉四磺酸钠(TPPSNa) |
97 |
WYQ |
2024-12-25 |
64804 |
DBCO-CONH-PEG12-CH2CH2COONHS的结构式 |
66 |
zyl |
2024-12-25 |
64805 |
cas:1353016-70-2,DBCO-acid,抗体偶联药物 |
95 |
h |
2024-12-25 |
64806 |
cas:98604-88-7,bis(2,5-dioxopyrrolidin-1-yl) 4,4'-disulfanediyldibutanoate |
136 |
h |
2024-12-25 |
64807 |
四-[3-甲氧基-4-(N-咔唑)正丁氧苯基]卟啉(4C4-TPP) |
97 |
WYQ |
2024-12-25 |
64808 |
Ald-Ph-amido-PEG3-C1-Boc,1007215-94-2,ADC试剂 |
65 |
hyy |
2024-12-25 |
64809 |
mPEG3-Hydrazide,甲氧基三聚乙二醇-酰肼 |
129 |
wyh |
2024-12-25 |
64810 |
DBCO-CONH-PEG12-CH2CH2COOH的介绍 |
62 |
zyl |
2024-12-25 |
64811 |
cas:1324007-10-4,2,3,4,5,6-pentafluorophenyl 1-[(4-formylphenyl)formamido]-3,6,9,12-tetraoxapentadecan-15-oate |
75 |
h |
2024-12-25 |
64812 |
唑来膦酸脂质体,Zoledronic Acid Liposome |
117 |
axc |
2024-12-25 |
64813 |
不对称酰胺基卟啉5-(4-棕榈酸酰亚胺基)苯基-10,15,20-三苯基卟啉(PITPPH2) |
97 |
WYQ |
2024-12-25 |
64814 |
盐酸拓扑替康脂质体(聚乙二醇化),Topotecan Hydrochloride Liposome (PEGylated) |
115 |
axc |
2024-12-25 |
64815 |
DBCO-CONH-PEG4-CH2CH2COONHS的结构式 |
81 |
zyl |
2024-12-25 |
64816 |
perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
75 |
h |
2024-12-25 |
64817 |
他莫昔芬脂质体,Tamoxifen Liposome |
83 |
axc |
2024-12-25 |
64818 |
2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate |
90 |
h |
2024-12-25 |
64819 |
Methyltetrazine-CH2NHCO-PEG9-Biotin |
74 |
zyl |
2024-12-25 |
64820 |
藤黄酸脂质体,Gambogic Acid Liposome |
71 |
axc |
2024-12-25 |
64821 |
cas:1006592-59-1,2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate |
70 |
h |
2024-12-25 |
64822 |
Ald-Ph-amido-PEG3-C2-Pfp ester,2101206-21-5,抗体- 药物偶联物 |
62 |
hyy |
2024-12-25 |
64823 |
mPEG6-N3,甲氧基六聚乙二醇叠氮 |
62 |
wyh |
2024-12-25 |
64824 |
阿达帕林弹性脂质体,Adapalene Elastic Liposome |
117 |
axc |
2024-12-25 |
64825 |
5-对-(4-溴丁氧基)苯基-10,15,20-三苯基卟啉(BrBPTPP) |
64 |
WYQ |
2024-12-25 |
64826 |
cas:1347750-84-8,MAL-Tetra-EG-OPFP,抗体偶联药物 |
60 |
h |
2024-12-25 |
64827 |
Methyltetrazine-CH2NHCO-PEG4-Biotin cas:1962919-31-8 生物素-四聚乙二醇-甲基四嗪 |
61 |
zyl |
2024-12-25 |
64828 |
甲氧基五聚乙二醇-巯基,mPEG5-SH |
65 |
wyh |
2024-12-25 |
64829 |
Adapalene Flexible Liposome 阿达帕林柔性脂质体 |
80 |
axc |
2024-12-25 |
64830 |
1-((1r,4r)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
49 |
h |
2024-12-25 |
64831 |
Ald-Ph-amido-PEG2-C2-Pfp ester,2101206-60-2,ADC试剂 |
114 |
hyy |
2024-12-25 |
64832 |
Adapalene Thermosensitive Liposome 阿达帕林热敏脂质体 |
61 |
axc |
2024-12-25 |
64833 |
Methyltetrazine-CH2NHCO-PEG8-CH2CH2NHMal cas:2143968-05-0 |
63 |
zyl |
2024-12-25 |
64834 |
石墨烯/酞菁钴(GR/CoPc)复合材料 |
184 |
WYQ |
2024-12-25 |
64835 |
cas:663599-00-6,1-(4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
72 |
h |
2024-12-25 |
64836 |
Me-Tet-PEG3-Maleimide cas:2141976-31-8 |
118 |
zyl |
2024-12-25 |
64837 |
四磺酸基酞菁氯化铝(AlClPcTS),分子式:C32H16AlClN8 |
101 |
WYQ |
2024-12-25 |
64838 |
阿达帕林脂质体,Adapalene Liposome |
89 |
axc |
2024-12-25 |
64839 |
金属酞菁-MXene复合材料,结合了金属酞菁和MXene的优异性能 |
96 |
WYQ |
2024-12-25 |
64840 |
Methyltetrazine-CH2NHCO-PEG9-CH2CH2COONHS cas:2143955-78-4 Me-Tet-PEG9-NHS |
92 |
zyl |
2024-12-25 |
64841 |
维生素P4脂质体,Vitamin P4 Liposome |
100 |
axc |
2024-12-25 |
64842 |
ld-Ph-amido-PEG2-C2-NHS ester,1807521-07-8,抗体- 药物偶联物 |
99 |
hyy |
2024-12-25 |
64843 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
179 |
WYQ |
2024-12-25 |
64844 |
cas:890409-86-6,3-(methylsulfonyl)-2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)butanoate |
143 |
h |
2024-12-25 |
64845 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
143 |
WYQ |
2024-12-25 |